Week 304 Review - Jubilee flys but it's not enough to stop a loss

It was looking like quite a good week but on the last few days there were small drops across some of my biggest holdings, compounded by cashing in some profit, so I ended up with the deficit between cost and value increasing by £2,042 to £27,864, but thanks to re-investing some profits the overall portfolio value only dropped by about half that to £118,607.

There were no big falls this week, but DDDD:4D Pharma dropping 4% and OPTI:Optibiotix dropping 1p was enough to do most of the damage.

JLP:Jubilee Metals makes up for being worst performer last week by smashing Share of the Week when it increased by 58% of my purchase price. It's now up by 357% and making £7,724 potential profit. However, I've done all the top slicing I want to, and plan to hold the last 50,000 shares longer term. Ideally it will be 100p a share before I sell any more, so I can get £1,000 by selling just 1,000 shares. Proper piggy bank!

Reasonably flat as the cost line goes up yet again.

Not as low as 2 weeks ago, so fingers crossed we'll be upwards again next week.

Here's the ISA and shares portfolio after week 44 of year 6.

			Weekly Change
Cash	£42.83		+£2.48
Portfolio cost	£70,691.67		+£0
Portfolio sell value (bid price-commission)	£57,705.35	(-18.4%)	+£55.51
Potential profits	£7,724.08		+£1,250.00
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£6,218.52		+£0
Yr 6 projected avg monthly profit	£608.74	(16.7%)	-£14.15
Total Dividends	£1,343.15		+£0
Total Profit from sales	£26,645.13		+£0
Average monthly cash profit	£395.10	(10.8%)	-£1.31
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	63%		+0%

This account actually went up by £55 thanks to JLP:Jubilee Metals shooting up by £1,250 and cancelling out the other losses. The increase was due to news of more tailings dumps secured for feeding the PGM circuits. Cash went up when I went into the account and added up what was actually there and found it was a few quid more than I thought. I haven't a clue why.

Completely flat.

Even the gloomy chart is flat this week.

The SIPP looks like this after week 288 overall and week 28 of year 6.

			Weekly Change
Cash	£308.37		-£210.05
Portfolio cost	£72,795.88		+£1,203.54
Portfolio sell value (bid price - commission)	£58,862.85	(-19.1%)	-£2,039.98
Potential profits	£2,274.33		-£787.38
Yr 6 Dividends	£874.51		+£0
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£7,196.19		+£1,010.19
Yr 6 projected avg monthly profit	£1,233.46	(33.8%)	+£116.39
Total Dividends	£2,941.59		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£22,655.63		+£1,010.19
Average monthly cash profit	£374.29	(10.3%)	+£13.94
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	57%		+2%

I decided to do what I mentioned last week and sacrifice some CAML:Central Asia Metals shares in order to get more magic formula shares, as this has been working really well but I had showing poor discipline in selling them to buy gut bacteria shares. Having said that, I also sacrificed a few more CAML for some more gut bacteria shares too!

I sold 300 CAML:Central Asia Metals shares for 279.7p making £280.20 (50.1%) profit. Combined with the cash from the CAML dividend I was able to buy 871 shares in CEY:Centamin at 114.71 costing £1,008.07.

On Friday I sold another 400 CAML shares at 277.2p and made £366.60 (49.3%) profit. I used the proceeds to buy another 2,373 shares in OPTI:Optibiotix at 50.184p costing £1,199.82 and bringing the average price in my SIPP down to 61.6p. My total OPTI:Optibiotix holding is now over 158,000 shares which gives me 8,000 shares I can play with to bank some profits while I keep the 150,000 long term.

The sales took me over my 10% target for long term performance for the first time in ages, and the performance over the first 6 months of year 6 has been spectacular. I suspect I won't be able to keep it up all year.

More of a dip as there was no JLP:Jubilee Metals to bail out the drops in this account.

That's a worry, as it's below the low from 2 weeks ago. It's my gut bacteria and gold shares letting me down.

The trading account looks like this after week 254 overall and week 46 of year 5.

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£1,429.31	(-39.8%)	-£58.44
Potential profits	£0.00		+£0
Year 5 Dividends	£12.18		+£0
Year 5 Profit	£651.51		+£0
Yr 5 projected avg monthly profit	£62.52	(31.6%)	-£1.39
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£17.03	(8.6%)	-£0.06
(Sold stocks profit + Dividends - Fees / Months)

Everything in the account dropped this week, so it's looking somewhat grim.

Almost down to the injection line.

The only glimmer of hope is that the decline is less steep than the rise was. I don't think that means anything though, and it's not far from being below the 12-month low.

Shocking announcement from MTFB:Motif Bio this week. They are planning a share consolidation of one share for every 220 owned, resulting in under 3 million shares remaining, and then doing a thumping great share issue which effectively dilutes existing shareholders out of existence. I will have 34 shares costing £70 each. There's one thing I can guarantee, these shares are never getting to £70, so it's just a question of when I cut my losses. I guess it's better than losing everything, but a harsh lesson in the dangers of investing in junior pharma companies.

OPTI:Optibiotix results are due either next week or the week after. Not expecting any surprises in them, but it would be good to get them out of the way so we can prepare for the first Sweetbiotix news. I'm longing for that day...